methotrexate has been researched along with Chronic Inflammatory Demyelinating Polyradiculoneuropathy in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Acar Arslan, E; Aksoy, A; Aksoy, E; Aliyeva, N; Ayanoğlu, M; Bektaş, Ö; Bodur, M; Canpolat, M; Çobanoğulları Direk, M; Gençpınar, P; Güleç, A; Gümüş, H; Gürkaş, E; Hız Kurul, S; Kanmaz, S; Keskin Yılmaz, S; Kızılırmak, AB; Kömür, M; Okuyaz, Ç; Olgaç Dündar, N; Öz Tuncer, G; Öztoprak, Ü; Öztürk, S; Per, H; Sarıkaya Uzan, G; Teber, S; Tekgül, H; Tosun, A; Ünalp, A; Ünay, B; Vural, A; Yıldırım, Ç; Yılmaz, Ü; Yiş, U; Yousefi, M; Yüksel, D | 1 |
| Aatif Siddique, R; Iftikhar, S; Mehreen, S; Muhammad, A; Shahid, S | 1 |
| Brassington, R; Gunn, AA; Hughes, RA; Mahdi-Rogers, M; van Doorn, PA | 1 |
| Hughes, RA; Mahdi-Rogers, M; van Doorn, PA | 1 |
| Chalk, CH; Frost, C; Hughes, RA; Lunn, MP; Oaklander, AL; van Schaik, IN | 1 |
| Dyck, PJ | 1 |
| Díaz-Manera, J; Gallardo, E; Illa, I; Rojas-García, R | 1 |
| Dyck, PJ; Tracy, JA | 1 |
| Hughes, RA; Mahdi-Rogers, M; Swan, AV; van Doorn, PA | 1 |
| Antonini, G; Benedetti, L; Briani, C; Cocito, D; Falcone, Y; Fazio, R; Grimaldi, S; Jann, S; Matà, S; Nobile-Orazio, E; Paolasso, I; Sabatelli, M | 1 |
| Allen, DC; Chan, YC; Fialho, D; Hughes, RA; Reilly, MM | 1 |
| Menkes, DL; Smyth, S | 1 |
5 review(s) available for methotrexate and Chronic Inflammatory Demyelinating Polyradiculoneuropathy
| Article | Year |
|---|---|
Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Anti-Inflammatory Agents; Azathioprine; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Interferon beta-1a; Interferon-beta; Methotrexate; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Randomized Controlled Trials as Topic; Treatment Outcome | 2017 |
Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Anti-Inflammatory Agents; Azathioprine; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon beta-1a; Interferon-beta; Methotrexate; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Randomized Controlled Trials as Topic | 2013 |
Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
Topics: Adrenal Cortex Hormones; Azathioprine; Dexamethasone; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon beta-1a; Methotrexate; Methylprednisolone; Plasma Exchange; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Prednisone; Randomized Controlled Trials as Topic; Review Literature as Topic | 2017 |
Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies.
Topics: Adrenal Cortex Hormones; Animals; Antibodies, Monoclonal; Clinical Trials as Topic; Electrodiagnosis; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Methotrexate; Neurologic Examination; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Risk Assessment; Treatment Outcome | 2010 |
Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Anti-Inflammatory Agents; Azathioprine; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon beta-1a; Interferon-beta; Methotrexate; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Randomized Controlled Trials as Topic | 2010 |
1 trial(s) available for methotrexate and Chronic Inflammatory Demyelinating Polyradiculoneuropathy
| Article | Year |
|---|---|
Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study.
Topics: Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents; Disability Evaluation; Double-Blind Method; Female; Folic Acid; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pilot Projects; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Treatment Outcome; Vitamins | 2009 |
7 other study(ies) available for methotrexate and Chronic Inflammatory Demyelinating Polyradiculoneuropathy
| Article | Year |
|---|---|
Pediatric-Onset Chronic Inflammatory Demyelinating Polyneuropathy: A Multicenter Study.
Topics: Azathioprine; Child; Female; Humans; Immunoglobulins, Intravenous; Male; Methotrexate; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Retrospective Studies | 2023 |
Efficacy of azathioprine and methotrexate in patients with chronic inflammatory demyelinating polyneuropathy (CIDP).
Topics: Adolescent; Adult; Azathioprine; Humans; Immunosuppressive Agents; Methotrexate; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Prednisolone | 2023 |
Adjuvant methotrexate in CIDP.
Topics: Humans; Immunosuppressive Agents; Methotrexate; Models, Molecular; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Randomized Controlled Trials as Topic | 2009 |
Response to methotrexate in a chronic inflammatory demyelinating polyradiculoneuropathy patient.
Topics: Disability Evaluation; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Neural Conduction; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Treatment Outcome | 2009 |
Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Axons; Azathioprine; Child; Cyclophosphamide; Cyclosporine; Drug Resistance; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Interferon beta-1a; Interferon-alpha; Interferon-beta; Italy; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Plasmapheresis; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Remission Induction; Retrospective Studies; Rituximab; Severity of Illness Index; Treatment Outcome; Young Adult | 2011 |
Treatment of chronic inflammatory demyelinating polyradiculoneuropathy with methotrexate.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Disability Evaluation; Female; Humans; Male; Methotrexate; Middle Aged; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Retrospective Studies; Treatment Outcome | 2006 |
Coincident membranous glomerulonephritis and chronic inflammatory demyelinating polyradiculoneuropathy: questioning the autoimmunity hypothesis.
Topics: Adult; Age of Onset; Autoimmune Diseases; Disease Progression; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Kidney; Male; Methotrexate; Peripheral Nerves; Plasmapheresis; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Treatment Outcome | 2008 |